Kidney Disease Market Report 2026

Kidney Disease Market Overview

• Kidney Disease market size has reached to $114.39 billion in 2025 • Expected to grow to $159.58 billion in 2030 at a compound annual growth rate (CAGR) of 6.9% • Growth Driver: Surging Incidence Of Kidney Diseases Fuels Growth In The Kidney Disease Market • Market Trend: Innovative Dialysis Solutions Supporting Patient-Centered Care • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Kidney Disease Market?

Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. The kidneys are vital organs responsible for filtering waste and excess fluids from the blood, regulating electrolyte balance, and producing hormones that control blood pressure and red blood cell production. The main types of treatments for kidney disease are medication, dialysis, surgery, and others. Medication refers to the use of drugs or pharmaceutical substances to treat, manage, or prevent various medical conditions, such as health problems related to kidney diseases. The treatments are indicated for acute kidney injury, chronic kidney disease, end-stage renal disease, and others through oral and parenteral routes of administration. These are used by various end-users such as hospitals, diagnostic laboratories, and others.

What Is The Kidney Disease Market Growth Forecast?

The kidney disease market size is expected to see strong growth in the next few years. It will grow to $159.58 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to aging global population with higher renal risk, increasing adoption of home-based dialysis, rising investment in kidney disease research, growing focus on early screening programs, expanding access to renal care in emerging markets. Major trends in the forecast period include rising focus on early detection and disease management, growing adoption of dialysis and renal replacement therapies, increasing demand for personalized kidney disease treatment, expansion of multidisciplinary care models for renal patients, improved patient awareness and preventive care initiatives.

Global Kidney Disease Market Segmentation

1) By Treatment: Medication, Dialysis, Surgery, Other Treatments 2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indications 3) By Route Of Administration: Oral, Parenteral 4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users Subsegments: 1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants 2) By Dialysis: Hemodialysis, Peritoneal Dialysis 3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery 4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care

What Is The Driver Of The Kidney Disease Market?

The increased incidence of kidney diseases is expected to propel the growth of the kidney disease market going forward. Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. Kidney disorder medications are used to lower patients' blood pressure and reduce protein loss, slowing the progression of kidney damage, managing symptoms, and preventing complications. For instance, in June 2023, according to Kidney Research UK, a UK-based charitable organization that conducts research and advocacy efforts to improve understanding, prevention, and treatment of kidney diseases, an estimated 7.19 million people in the UK were affected by chronic kidney disease in 2023, representing more than 10% of the UK population and projected to increase to 7.61 million people by 2033. Therefore, the increased incidence of kidney diseases is driving the growth of the kidney disease industry.

Key Players In The Global Kidney Disease Market

Major companies operating in the kidney disease market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, AstraZeneca plc, Sanofi S.A., Bristol-Myers Squibb Company, AbbVie Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Vertex Pharmaceuticals Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Lupin Limited, Aurobindo Pharma Limited

Global Kidney Disease Market Trends and Insights

Major companies operating in the kidney disease market are focusing on incorporating technology-driven innovations such as compact, cartridge-based hemodialysis systems to enhance treatment flexibility, patient usability, and workflow efficiency. Compact, cartridge-based hemodialysis systems are portable dialysis devices that use disposable dialysate cartridges instead of traditional bagged fluids, enabling capabilities such as automated dialysate preparation, simplified setup, and improved suitability for home-based therapy. For instance, in November 2024, Quanta Dialysis Technologies, a UK-based dialysis technology company, received FDA clearance for the Quanta Dialysis System, a cartridge-based hemodialysis system designed to support home hemodialysis and flexible care-setting deployment, featuring a compact footprint, on-demand dialysate generation, and an intuitive touchscreen interface. The quanta dialysis system improves patient autonomy, ease of treatment delivery, and operational efficiency across dialysis settings.

What Are Latest Mergers And Acquisitions In The Kidney Disease Market?

In January 2023, AstraZeneca Pharmaceuticals LP, a US-based biopharmaceutical company, acquired CinCor Pharma Inc. for $1.8 billion. Through this acquisition, AstraZeneca intends to enhance its cardiorenal portfolio by incorporating CinCor's promising compound, baxdrostat (CIN-107). Baxdrostat is an aldosterone synthase inhibitor (ASI) specifically designed to lower blood pressure in patients with treatment-resistant hypertension, including those with chronic kidney disease. CinCor Pharma Inc. is a US-based clinical-stage biopharmaceutical company specializing in kidney disease medications and treatments.

Regional Outlook

North America was the largest region in the kidney disease market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Kidney Disease Market?

The kidney disease market consists of revenues earned by providing services such as hemodialysis, peritoneal dialysis, and kidney transplantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The kidney disease also includes sales of drugs like galafold, sibnayal, tarpeyo, and cystadrops. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Kidney Disease Market Report 2026?

The kidney disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the kidney disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.